Do international kidney guidelines support the use of the creatinine-cystatin C based eGFR formula in a screening population? What exceptions might there be for its clinical use compared to the creatinine formula?
Abstract
The use of creatinine-cystatin C based eGFR formulas is supported by international guidelines for increased accuracy in specific populations, although adoption may be limited by cystatin C assay availability.
Fields of Study & Subjects
Chronic Kidney Disease and Diabetes
Acute Kidney Injury Research
Clinical Laboratory Practices and Quality Control
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 26 February 2026
- Language
- EN